FDA Drug Shortages

1,660 drug shortages total

Browse FDA drug shortages by generic name, company, and status. RegDataLab tracks 1,660 drug shortages from official FDA sources, updated on an ongoing basis.

FDA Drug Shortages (page 1 of 34)

Drug shortages	Details
Bendamustine Hydrochloride Injection, Solution	To Be Discontinued — Cephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.)
Glycopyrrolate Injection	To Be Discontinued — Fresenius Kabi USA, LLC
Dextrose Monohydrate 5% Injection	Current — Baxter Healthcare
Lopinavir and Ritonavir Tablet	To Be Discontinued — AbbVie Inc.
Morphine Sulfate Suppository	To Be Discontinued — Padagis US LLC
Morphine Sulfate Suppository	To Be Discontinued — Padagis US LLC
Ritonavir Oral Powder	To Be Discontinued — AbbVie Inc.
Doxycycline Hyclate Tablet, Delayed Release	To Be Discontinued — Teva Pharmaceuticals USA, Inc.
Lidocaine Hydrochloride Injection	Current — Anthea Pharma
Dexamethasone Sodium Phosphate Injection	Current — Somerset Therapeutics, LLC
Ropivacaine Hydrochloride Injection	Current — Somerset Therapeutics, LLC
Lopinavir and Ritonavir Tablet	To Be Discontinued — AbbVie Inc.
Ropivacaine Hydrochloride Injection	Current — Somerset Therapeutics, LLC
Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered	To Be Discontinued — GlaxoSmithKline
Atropine Sulfate Injection	Current — Somerset Therapeutics, LLC
Bupivacaine Hydrochloride Injection	Current — Aspiro Pharma Limited
Belladonna and Opium Suppository	To Be Discontinued — Padagis US LLC
Lopinavir and Ritonavir Oral Solution	To Be Discontinued — AbbVie Inc.
Morphine Sulfate Suppository	To Be Discontinued — Padagis US LLC
Sodium Acetate Injection	Current — Somerset Therapeutics, LLC
Belladonna and Opium Suppository	To Be Discontinued — Padagis US LLC
Lidocaine Hydrochloride Injection	Current — Anthea Pharma
Lidocaine Hydrochloride Injection	Current — Anthea Pharma
Doxycycline Hyclate Tablet, Delayed Release	To Be Discontinued — Teva Pharmaceuticals USA, Inc.
Ropivacaine Hydrochloride Injection	Current — Somerset Therapeutics, LLC
Hydromorphone Hydrochloride Suppository	To Be Discontinued — Padagis US LLC
Lopinavir and Ritonavir Tablet	To Be Discontinued — AbbVie Inc.
Lopinavir and Ritonavir Tablet	To Be Discontinued — AbbVie Inc.
Succinylcholine Chloride Injection	To Be Discontinued — Fresenius Kabi USA, LLC
Sodium Acetate Injection	Current — Somerset Therapeutics, LLC
Lidocaine Hydrochloride Injection	Current — Anthea Pharma
Bupivacaine Hydrochloride Injection	Current — Aspiro Pharma Limited
Bupivacaine Hydrochloride Injection	Current — Somerset Therapeutics, LLC
Dexamethasone Sodium Phosphate Injection	Current — Fresenius Kabi USA, LLC
Bupivacaine Hydrochloride Injection	Current — Aspiro Pharma Limited
Atropine Sulfate Injection	Current — Somerset Therapeutics, LLC
Lidocaine Hydrochloride Injection	Current — Anthea Pharma
Dexmedetomidine Hydrochloride Injection	Current — Somerset Therapeutics, LLC
Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered	To Be Discontinued — GlaxoSmithKline
Bupivacaine Hydrochloride Injection	Current — Somerset Therapeutics, LLC
Dextrose Monohydrate 5% Injection	Current — Baxter Healthcare
Morphine Sulfate Suppository	To Be Discontinued — Padagis US LLC
Bupivacaine Hydrochloride Injection	Current — Aspiro Pharma Limited
Aspirin Suppository	To Be Discontinued — Padagis US LLC
Hydrocortisone Acetate Suppository	To Be Discontinued — Padagis US LLC
Glycopyrrolate Injection	To Be Discontinued — Fresenius Kabi USA, LLC
Atropine Sulfate Injection	Current — Somerset Therapeutics, LLC
Dexamethasone Sodium Phosphate Injection	Current — Fresenius Kabi USA, LLC
Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered	To Be Discontinued — GlaxoSmithKline
Lidocaine Hydrochloride Injection	Current — Anthea Pharma